Lumos Pharma, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP

55028X109
SEDOL

N/A
CIK

0001126234

www.lumos-pharma.com
LEI:
FIGI: BBG001CDB921
LUMO

Lumos Pharma, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Biotechnology
AI
PROFILER
NAME
Lumos Pharma, Inc.
ISIN
US55028X1090
TICKER
LUMO
MIC
XNAS
REUTERS
LUMO.OQ
BLOOMBERG
LUMO US
GIF DE 728x90
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants

Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.

Mi., 23.10.2024       Lumos Pharma
US55028X1090

NEW YORK, Oct. 23, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Lumos Pharma, Inc. (NASDAQ: LUMO) and its board of directors concerning the proposed acquisition of the company by Double Point Ventures LLC. Stockholders will receive $4.25 and one contingent value right for each share of Lumos Pharma stock that they hold. The transaction is expected to close by the end of 2024.

If you are a stockholder of Lumos Pharma, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/lumo/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Mi., 23.10.2024       Lumos Pharma
US55028X1090

NEW YORK, Oct. 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Martin Midstream Partners L.P. (NASDAQ: MMLP)'s sale to Martin Resource Management Corporation for $4.02 per common unit. If you are a Martin Midstream shareholder, click here to learn more about your legal rights and options.

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S